Ignite Creation Date:
2024-05-06 @ 7:44 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06119217
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-09-22
Brief Title:
Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients
Sponsor:
Organization:
Trishula Therapeutics Inc